[ Search ] [ Legislation ]
[ Home ] [ Back ] [ Bottom ]
91_SB1239
LRB9106716MWgc
1 AN ACT concerning biotechnology.
2 Be it enacted by the People of the State of Illinois,
3 represented in the General Assembly:
4 Section 5. The Biotechnology Sector Development Act is
5 amended by changing Sections 10, 15, and 20 and by adding
6 Sections 30, 35, 40, 50, 60, 65, 70, 75, 80, 85, 90, 100,
7 110, 115, 120, and 130 as follows:
8 (20 ILCS 230/10)
9 Sec. 10. Sector program. The Department of Agriculture,
10 in cooperation with the Department of Commerce and Community
11 Affairs and the Illinois Coalition, shall establish a
12 targeted sector program in the area of biotechnology. In
13 fulfillment of this purpose, the Department of Agriculture is
14 authorized to:
15 (a) Analyze on an ongoing basis the state of the
16 biotechnology sector in Illinois, including, but not limited
17 to, its strengths and weaknesses, its opportunities and
18 risks, its emerging products, processes, and market niches,
19 the commercialization of its related technology, its capital
20 availability, its education and training needs, and its
21 infrastructure development.
22 (b) Work in conjunction with the Biotechnology Advisory
23 Council created under this Act.
24 (c) Develop a resource guide for use in promoting the
25 biotechnology sector in Illinois.
26 (d) Explore the feasibility of conducting seminars to
27 provide both entrepreneurs and investors with information
28 about the biotechnology sector in Illinois.
29 (e) Operate, internally or on a contractual basis, an
30 equipment resource referral service to identify available
31 surplus equipment that could be used by biotechnology
-2- LRB9106716MWgc
1 entrepreneurs.
2 (Source: P.A. 88-584, eff. 8-12-94.)
3 (20 ILCS 230/15)
4 Sec. 15. Biotechnology Advisory Council. There is
5 created a Biotechnology Advisory Council within the
6 Department of Agriculture. The Council is composed of the
7 Directors, or their designees, of the Department of
8 Agriculture and the Department of Commerce and Community
9 Affairs; the executive director, or his or her designee, of
10 the Illinois Board of Higher Education; 2 representatives of
11 the public higher education community appointed by the
12 Governor; 2 representatives of the private higher education
13 community appointed by the Governor; and 4 representatives of
14 the private sector appointed by the Governor. The members
15 appointed by the Governor shall be qualified based upon their
16 demonstrated knowledge, skill, and expertise in the field of
17 biotechnology.
18 Appointed members shall serve 2-year terms and may be
19 reappointed. Any vacancy occurring before the expiration of
20 the term of the vacating member shall be filled by
21 appointment for the remainder of that term. Members shall
22 serve without compensation but shall be reimbursed for
23 ordinary and necessary expenses incurred in the performance
24 of their duties. The Director of the Department of
25 Agriculture shall serve as chair.
26 The Governor shall make initial appointments no later
27 than 60 days after the effective date of this Act.
28 The Department of Agriculture and the Department of
29 Commerce and Community Affairs shall cooperate with the
30 Council to fulfill the purposes of this Act. The Department
31 of Agriculture shall provide the Council with necessary staff
32 and administrative support.
-3- LRB9106716MWgc
1 (Source: P.A. 88-584, eff. 8-12-94.)
2 (20 ILCS 230/20)
3 Sec. 20. Scope and functions. The Biotechnology
4 Advisory Council shall:
5 (a) Assist the Department of Agriculture in the
6 development of a strategic plan for developing and promoting
7 the biotechnology sector in this State, building upon the
8 1993 report of recommendations of the Biotechnology Working
9 Group convened by the Department of Agriculture.
10 (b) Recommend to the Department of Agriculture and the
11 Department of Commerce and Community Affairs changes in
12 policy or law in the areas of labor availability and
13 training, regulation, capital development, technology
14 transfer, support facilities, and industrial recruiting that
15 will promote the development of the biotechnology sector in
16 this State.
17 (c) Recommend measures to enhance public and private
18 collaboration in the biotechnology sector.
19 (Source: P.A. 88-584, eff. 8-12-94.)
20 (20 ILCS 230/30 new)
21 Sec. 30. Creation of Illinois Biotechnology Development
22 Authority. There is created an entity to be known as the
23 Illinois Biotechnology Development Authority. The Authority
24 may maintain an office or branch office anywhere in the State
25 and may use, without the payment of rent, any office
26 facilities that the State may conveniently make available to
27 it.
28 (20 ILCS 230/35 new)
29 Sec. 35. Purpose. The purposes of the Illinois
30 Biotechnology Development Authority are:
31 (a) to develop and operate comprehensive
-4- LRB9106716MWgc
1 information systems for the improvement and coordination
2 of all aspects of biotechnology;
3 (b) to define, develop, evaluate, and correlate
4 State and local programs and projects associated with the
5 improvement of biotechnology;
6 (c) to act as a central repository and clearing
7 house for federal, State, and local research studies,
8 plans, projects, proposals, and other information
9 relating to all aspects of biotechnology and to encourage
10 educational programs for citizen support of State and
11 local efforts to make those improvements;
12 (d) to undertake research studies to aid in
13 accomplishing its purposes;
14 (e) to advise and to make recommendations to the
15 Governor and the General Assembly on policies relating to
16 biotechnology;
17 (f) to direct all other agencies under the
18 jurisdiction of the Governor to provide whatever
19 assistance and information the Authority may lawfully
20 require to carry out its functions; and
21 (g) to exercise any other powers that are
22 reasonable and necessary to fulfill the responsibilities
23 of the Authority under this Act and to comply with the
24 requirements of applicable federal law or regulation.
25 (20 ILCS 230/40 new)
26 Sec. 40. Members of Authority; terms.
27 (a) The governing and administrative powers of the
28 Illinois Biotechnology Development Authority shall be vested
29 in a Board consisting of 4 nonvoting members and 13 voting
30 members appointed or designated as follows:
31 (1) the Director of Commerce and Community Affairs
32 or his or her designee;
33 (2) the Director of Agriculture or his or her
-5- LRB9106716MWgc
1 designee;
2 (3) the dean of a public university with a research
3 park college of agriculture appointed by the Governor
4 with the advice and consent of the Senate;
5 (4) the dean of a public university with a research
6 park college of engineering appointed by the Governor
7 with the advice and consent of the Senate;
8 (5) the dean of a public college of medicine at a
9 university with a teaching hospital appointed by the
10 Governor with the advice and consent of the Senate;
11 (6) four members of the General Assembly, one each
12 appointed by the President of the Senate, the Minority
13 Leader of the Senate, the Speaker of the House of
14 Representatives, and the Minority Leader of the House of
15 Representatives; these 4 members shall be ex officio
16 nonvoting members;
17 (7) the President of the Chicago Technology Park;
18 (8) the President of the Illinois Coalition;
19 (9) two representatives from Illinois agricultural
20 trade associations appointed by the Governor with the
21 advice and consent of the Senate; and
22 (10) four members of the general public to be
23 appointed by the Governor with the advice and consent of
24 the Senate.
25 (b) All of the members shall be residents of the State.
26 All of the members appointed by the Governor shall have
27 recognized ability and experience in one or more of the
28 following areas: higher education, research and development,
29 science and technology, medicine, engineering, or
30 bioagricultural development. A Chairperson and
31 Vice-chairperson of the Board shall be elected by the Board
32 annually from among its members.
33 (c) The terms of all members of the Board shall begin 30
34 days after the effective date of this Act. Of the members
-6- LRB9106716MWgc
1 initially appointed by the Governor, 4 shall serve until the
2 third Monday in January, 2002, and 5 shall serve until the
3 third Monday in January, 2003. Each successor shall hold
4 office for a term of 4 years commencing the third Monday in
5 January of the year in which his or her term commences,
6 except in case of an appointment to fill a vacancy. In case
7 of vacancy when the Senate is not in session, the Governor
8 may make a temporary appointment until the next meeting of
9 the Senate when a person shall be nominated to fill the
10 office and any person so nominated who is confirmed by the
11 Senate shall hold office during the remainder of the term and
12 until a successor is appointed and qualified.
13 (20 ILCS 230/50 new)
14 Sec. 50. Executive director. The Governor, with the
15 advice and consent of the Senate, shall appoint an executive
16 director of the Authority. The executive director shall
17 employ, in accordance with the provisions of the Illinois
18 Personnel Code, any administrative, professional, clerical,
19 and other personnel that may be required. The executive
20 director may organize the staff of the Authority as he or she
21 may deem appropriate.
22 (20 ILCS 230/60 new)
23 Sec. 60. General powers.
24 (a) The Illinois Biotechnology Development Authority
25 shall have the following powers, duties, and
26 responsibilities:
27 (1) to enter into loans, contracts, mortgages, and
28 inter-governmental, inter-agency, or other agreements in
29 furtherance of any project approved by the Authority or
30 otherwise in any matter connected with any of its
31 corporate purposes;
32 (2) to invest the funds of the Authority;
-7- LRB9106716MWgc
1 (3) to sue and be sued;
2 (4) to employ agents, employees, and independent
3 contractors necessary to carry out its corporate purposes
4 and to fix their compensation, benefits, and terms and
5 conditions of employment;
6 (5) to have and use a common seal and to alter the
7 seal at its discretion;
8 (6) to adopt all necessary ordinances, resolutions,
9 by-laws, and rules for the conduct of its business and
10 affairs and for the management and use of the projects
11 implemented, developed, constructed, acquired, and
12 improved in furtherance of its corporate purposes;
13 (7) to designate and change the fiscal year for the
14 Authority;
15 (8) to accept and expend appropriations for any
16 purpose of the Authority;
17 (9) as a designated intermediary organization, to
18 enter into agreements with and accept funds from the
19 Department of Commerce and Community Affairs, the
20 Department of Agriculture, and other State entities or
21 agencies for the purposes of this Act;
22 (10) to fix, determine, charge, and collect
23 premiums, fees, charges, costs, and expenses from any
24 person in connection with its activities under this Act;
25 (11) to create and establish reserve funds and
26 accounts that may be necessary or desirable to accomplish
27 its purposes under this Act and to deposit its available
28 moneys into the funds and accounts;
29 (12) to charge to and apportion among projects the
30 administrative costs and expenses of the Authority
31 incurred in the exercise of the powers and duties
32 conferred by this Act;
33 (13) to develop, construct, and improve any
34 project, either under its own direction or through
-8- LRB9106716MWgc
1 collaboration with any approved applicant; to acquire any
2 project, through purchase or otherwise, and to use for
3 that purpose proceeds derived from governmental loans or
4 grants or from any other legally authorized and available
5 source; and to hold title in the name of the Authority to
6 any projects or portions thereof;
7 (14) to lease, under one or more lease agreements,
8 all or parts of a project to the approved lessee or
9 lessees on any terms and conditions that may be
10 appropriate to further the purposes of this Act and to
11 maintain the credit of the Authority; and
12 (15) to have and exercise all powers and be subject
13 to all duties usually incident to boards of directors of
14 corporations.
15 (b) For the purpose of this Section, "project" means any
16 activities, programs, or initiatives to further the purpose
17 of this Act and to enhance the position of Illinois as a
18 leader in biotechnology and the commercialization and
19 application of new products and processes, with particular
20 emphasis on building on and preserving Illinois' leading
21 position in the lifesciences biotechnology sector,
22 bioagriculture sector, and biomedical technology transfer and
23 commercialization.
24 (20 ILCS 230/65 new)
25 Sec. 65. Board members; compensation. The members of
26 the Illinois Biotechnology Development Authority shall
27 receive no compensation for the performance of their duties
28 as members, but each member shall be reimbursed for
29 reasonable and necessary expenses while engaged in the
30 performance of his or her duties.
31 (20 ILCS 230/70 new)
32 Sec. 70. Bonds and notes.
-9- LRB9106716MWgc
1 (a)(1) The Illinois Biotechnology Development Authority
2 may, with the written approval of the Governor, at any time
3 and from time to time issue bonds and notes for any corporate
4 purpose, including the establishment of reserves and the
5 payment of interest. In this Act, the term "bonds" includes
6 notes of any kind, interim certificates, refunding bonds, or
7 any other evidence of obligation.
8 (2) The bonds of any issue shall be payable solely from
9 the property or receipts of the Authority, including, without
10 limitation:
11 (A) fees, charges, or other revenues payable to the
12 Authority;
13 (B) payments by financial institutions, insurance
14 companies, or others pursuant to letters or lines of
15 credit, policies of insurance, or purchase agreements;
16 (C) investment earnings from funds or accounts
17 maintained pursuant to a bond resolution or trust
18 agreement; and
19 (D) proceeds of refunding bonds.
20 (3) Bonds shall be authorized by a resolution of the
21 Authority and may be secured by a trust agreement by and
22 between the Authority and a corporate trustee or trustees
23 that may be any trust company or bank having the powers of a
24 trust company within or without the State. Bonds shall:
25 (A) be issued at, above, or below par value for
26 cash or other valuable consideration and may mature at a
27 time or times, whether as serial bonds, as term bonds, or
28 both, not exceeding 40 years from their respective date
29 of issue; however, the length of the term of the bond
30 should bear a reasonable relationship to the value life
31 of the item financed;
32 (B) bear interest at the fixed or variable rate or
33 rates determined by the method provided in the resolution
34 or trust agreement;
-10- LRB9106716MWgc
1 (C) be payable at a time or times in the
2 denominations and form, either coupon, registered, or
3 both, and carry the registration and privileges as to
4 conversion and the replacement of mutilated, lost, or
5 destroyed bonds that the resolution or trust agreement
6 may provide;
7 (D) be payable in lawful money of the United States
8 at a designated place;
9 (E) be subject to the terms of purchase, payment,
10 redemption, refunding, or refinancing that the resolution
11 or trust agreement provides;
12 (F) be executed by the manual or facsimile
13 signatures of the officers of the Authority designated by
14 the Authority, which signatures shall be valid at
15 delivery even for one who has ceased to hold office; and
16 (G) be sold in the manner and upon the terms
17 determined by the Authority.
18 (b) Any resolution or trust agreement may contain
19 provisions that shall be a part of the contract with the
20 holders of the bonds as to:
21 (1) pledging, assigning, or directing the use,
22 investment, or disposition of receipts of the Authority or
23 the proceeds or benefits of any contract and conveying or
24 otherwise securing any property or property rights;
25 (2) the setting aside of loan funding deposits, debt
26 service reserves, capitalized interest accounts, cost of
27 issuance accounts, and sinking funds and the regulations,
28 investment, and disposition thereof;
29 (3) limitations on the purpose to which or the
30 investments in which the proceeds of sale of any issue of
31 bonds may be applied and restrictions to investment of
32 revenues or bond proceeds in government obligations for which
33 principal and interest are unconditionally guaranteed by the
34 United States of America;
-11- LRB9106716MWgc
1 (4) limitations on the issue of additional bonds, the
2 terms upon which additional bonds may be issued and secured,
3 and the terms upon which additional bonds may rank on a
4 parity with, or be subordinate or superior to, other bonds;
5 (5) the refunding or refinancing of outstanding bonds;
6 (6) the procedure, if any, by which the terms of any
7 contract with bondholders may be altered or amended and the
8 amount of bonds that and number of bondholders who must
9 consent thereto and the manner in which consent shall be
10 given;
11 (7) defining the acts or omissions that shall constitute
12 a default in the duties of the Authority to holders of bonds
13 and providing the rights or remedies of the holders in the
14 event of a default that may include provisions restricting
15 individual right of action by bondholders;
16 (8) providing for guarantees, pledges of property,
17 letters of credit, or other security or insurance for the
18 benefit of bondholders; and
19 (9) any other matter relating to the bonds that the
20 Authority determines appropriate.
21 (c) No member of the Authority nor any person executing
22 the bonds shall be liable personally on the bonds or subject
23 to any personal liability by reason of the issuance of the
24 bonds.
25 (d) The Authority may enter into agreements with agents,
26 banks, insurers, or others for the purpose of enhancing the
27 marketability of or as security for its bonds.
28 (e) A pledge by the Authority of revenues as security
29 for an issue of bonds shall be valid and binding from the
30 time when the pledge is made.
31 The revenues pledged shall immediately be subject to the
32 lien of the pledge without any physical delivery or further
33 act and the lien of any pledge shall be valid and binding
34 against any person having any claim of any kind in tort,
-12- LRB9106716MWgc
1 contract, or otherwise against the Authority, irrespective of
2 whether the person has notice.
3 No resolution, trust agreement or financing statement,
4 continuation statement, or other instrument adopted or
5 entered into by the Authority need be filed or recorded in
6 any public record other than the records of the Authority in
7 order to perfect the lien against third persons, regardless
8 of any contrary provision of law.
9 (f) The Authority may issue bonds to refund any of its
10 bonds then outstanding, including the payment of any
11 redemption premium and any interest accrued or to accrue to
12 the earliest or any subsequent date of redemption, purchase,
13 or maturity of the bonds. Refunding bonds may be issued for
14 the public purposes of realizing savings in the effective
15 costs of debt service, directly or through a debt
16 restructuring, for alleviating impending or actual default
17 and may be issued in one or more series in an amount in
18 excess of that of the bonds to be refunded.
19 (g) Bonds or notes of the Authority may be sold by the
20 Authority through the process of competitive bid or
21 negotiated sale.
22 (h) At no time shall the total outstanding bonds and
23 notes of the Authority exceed $100,000,000.
24 (i) The bonds and notes of the Authority shall not be
25 debts of the State.
26 (j) In no event may proceeds of bonds or notes issued by
27 the Authority be used to finance any structure that is not
28 constructed pursuant to an agreement between the Authority
29 and a party, that provides for the delivery by the party of a
30 completed structure constructed pursuant to a fixed price
31 contract, and that provides for the delivery of the structure
32 at a fixed price to be insured or guaranteed by a third party
33 determined by the Authority to be capable of completing
34 construction of that structure.
-13- LRB9106716MWgc
1 (20 ILCS 230/75 new)
2 Sec. 75. Moneys for payment of principal of and interest
3 on bonds. In the event that the Illinois Biotechnology
4 Development Authority determines that moneys of the Authority
5 will not be sufficient for the payment of the principal of
6 and interest on its bonds during the next State fiscal year,
7 the Chairperson, as soon as practicable, shall certify to the
8 Governor the amount required by the Authority to enable it to
9 pay the principal of and interest on the bonds. The Governor
10 shall submit the amount so certified to the General Assembly
11 as soon as practicable, but no later than the end of the
12 current State fiscal year. This Section shall not apply to
13 any bonds or notes as to which the Authority shall have
14 determined, in the resolution authorizing the issuance of the
15 bonds or notes, that this Section shall not apply. Whenever
16 the Authority makes such a determination, that fact shall be
17 plainly stated on the face of the bonds or notes and that
18 fact shall also be reported to the Governor.
19 In the event of a withdrawal of moneys from a reserve
20 fund established with respect to any issue or issues of bonds
21 of the Authority to pay principal or interest on those bonds,
22 the Chairman of the Authority, as soon as practicable, shall
23 certify to the Governor the amount required to restore the
24 reserve fund to the level required in the resolution or
25 indenture securing those bonds. The Governor shall submit the
26 amount so certified to the General Assembly as soon as
27 practicable, but no later than the end of the current State
28 fiscal year.
29 (20 ILCS 230/80 new)
30 Sec. 80. Legality for investment. Any financial
31 institution, investment company, insurance company, or
32 association and any personal representative, guardian,
33 trustee, or other fiduciary may legally invest any moneys
-14- LRB9106716MWgc
1 belonging to them or within their control in any bonds issued
2 by the Illinois Biotechnology Development Authority.
3 (20 ILCS 230/85 new)
4 Sec. 85. Tax exemption. The Illinois Biotechnology
5 Development Authority shall not be required to pay any taxes
6 or assessments of any kind whatsoever and its bonds, their
7 transfer, the interest payable on them, and any income
8 derived from them may be exempt by the election of the
9 Authority at the time of issuance and at all times from every
10 kind and nature of taxation by this State or by any of its
11 political subdivisions, municipal corporations, or public
12 agencies of any kind, except for estate, transfer, and
13 inheritance taxes, as provided in Section 90. For purposes of
14 Section 250 of the Illinois Income Tax Act, the exemption of
15 the income from bonds issued by the Authority shall terminate
16 after all of the bonds have been paid. The amount of the
17 income that shall be added and then subtracted on the
18 Illinois income tax return of a taxpayer, pursuant to Section
19 203 of the Illinois Income Tax Act, from federal adjusted
20 gross income or federal taxable income in computing Illinois
21 base income shall be the interest net of any bond premium
22 amortization.
23 (20 ILCS 230/90 new)
24 Sec. 90. Bond and notes; exemption from taxation. The
25 creation of the Illinois Biotechnology Development Authority
26 is in all respects for the benefit of the people of Illinois
27 and for the improvement of their health, safety, welfare,
28 comfort, and security and its purposes are public purposes.
29 In consideration thereof, the notes and bonds of the
30 Authority issued pursuant to this Act and the income
31 therefrom may be free from all taxation by the State or its
32 political subdivisions except for estate, transfer and
-15- LRB9106716MWgc
1 inheritance taxes. The exemption from taxation provided by
2 the preceding sentence shall apply to the income on any notes
3 or bonds of the Authority only if the Authority in its sole
4 judgment determines that the exemption enhances the
5 marketability of the bonds or notes or reduces the interest
6 rates that would otherwise be borne by the bonds or notes.
7 For purposes of Section 250 of the Illinois Income Tax Act,
8 the exemption of the income from bonds issued by the
9 Authority shall terminate after all of the bonds have been
10 paid. The amount of the income that shall be added and then
11 subtracted on the Illinois income tax return of a taxpayer,
12 pursuant to Section 203 of the Illinois Income Tax Act, from
13 federal adjusted gross income or federal taxable income in
14 computing Illinois base income shall be the interest net of
15 any bond premium amortization.
16 (20 ILCS 230/100 new)
17 Sec. 100. No taxing power; exemption from taxation. The
18 Illinois Biotechnology Development Authority shall not have
19 the power to levy taxes for any purpose. The exercise of the
20 powers granted by this Act shall be the increase of the
21 commerce, welfare, and prosperity and the improvement of the
22 health and living conditions of the public. As the
23 activities of the Authority or the operation and maintenance
24 of facilities or real or personal property by the Authority
25 or its agent will constitute the performance of an essential
26 public function, neither the Authority nor its agent shall be
27 required to pay any taxes or assessments, including mortgage
28 recording taxes, upon or in respect to any of the activities
29 of the Authority or any facility or real or personal property
30 acquired or used by the Authority or its agent under the
31 provisions of this Act and the income therefrom shall at all
32 times be free from taxation of any kind by the State and by
33 the municipalities and other political subdivisions of the
-16- LRB9106716MWgc
1 State.
2 (20 ILCS 230/110 new)
3 Sec. 110. Annual report. The Illinois Biotechnology
4 Development Authority shall keep an accurate account of all
5 its activities and its receipts and expenditures and shall
6 annually, in the month of January, make a report thereof to
7 its members and to the Governor, the State Comptroller, the
8 General Assembly, and the Illinois Economic and Fiscal
9 Commission. The report shall be a public record and open for
10 inspection at the offices of the Authority during normal
11 business hours. Among other matters, the report shall include
12 an assessment of the current state of the biotechnology
13 sector of the State and contain recommendations for new
14 initiatives and efforts to further enhance and position the
15 State's environment for the biotechnology for the future.
16 The requirement for reporting to the General Assembly
17 shall be satisfied by filing copies of the report with the
18 Speaker, the Minority Leader, and the Clerk of the House of
19 Representatives, and the President, the Minority Leader, and
20 the Secretary of the Senate, and the Legislative Research
21 Unit as required by Section 3.1 of the General Assembly
22 Organization Act and by filing any additional copies with the
23 State Government Report Distribution Center for the General
24 Assembly as required under paragraph (t) of Section 7 of the
25 State Library Act.
26 (20 ILCS 230/115 new)
27 Sec. 115. Biotechnology Projects Fund. The Biotechnology
28 Development Projects Fund is created as a special fund in the
29 State treasury. Grants and other moneys obtained by the
30 Illinois Biotechnology Authority from governmental entities
31 (other than the federal government), private sources, and
32 not-for-profit organizations for use in projects shall be
-17- LRB9106716MWgc
1 deposited into the Fund. Moneys in the Fund may be used by
2 the Authority, subject to appropriation, for undertaking
3 projects and for the operating and other expenses of the
4 Authority incidental to those projects.
5 (20 ILCS 230/120 new)
6 Sec. 120. Administrative action and review. The
7 Illinois Administrative Procedure Act and the rules and
8 regulations adopted thereunder shall apply to and govern all
9 administrative actions taken by the Authority, where
10 applicable, unless otherwise prescribed by this Act.
11 Judicial review of final administrative decisions may be had
12 in accordance with the Administrative Review Law.
13 (20 ILCS 230/130 new)
14 Sec. 130. Construction of Act. This Act shall be
15 liberally construed to achieve the purposes set forth in
16 Section 35 of this Act.
17 Section 10. The State Finance Act is amended by adding
18 Section 4.490 as follows:
19 (30 ILCS 105/5.490 new)
20 Sec. 5.490. The Biotechnology Projects Fund.
21 Section 99. Effective date. This Act takes effect upon
22 becoming law.
-18- LRB9106716MWgc
1 INDEX
2 Statutes amended in order of appearance
3 20 ILCS 230/10
4 20 ILCS 230/15
5 20 ILCS 230/20
6 20 ILCS 230/30 new
7 20 ILCS 230/35 new
8 20 ILCS 230/40 new
9 20 ILCS 230/50 new
10 20 ILCS 230/60 new
11 20 ILCS 230/65 new
12 20 ILCS 230/70 new
13 20 ILCS 230/75 new
14 20 ILCS 230/80 new
15 20 ILCS 230/85 new
16 20 ILCS 230/90 new
17 20 ILCS 230/100 new
18 20 ILCS 230/110 new
19 20 ILCS 230/115 new
20 20 ILCS 230/120 new
21 20 ILCS 230/130 new
22 30 ILCS 105/5.490 new